DKA Capital

DKA Capital (formerly Dansk Kapitalanlæg) is a well-established Danish PE fund investing in and developing knowledge-intensive growth

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Industries / Tags:

Detailed DKA Capital Information

Geographic Data

DKA Capital headquarters map

Address: Havnegade 39

City: Copenhagen

State: zealand

Zip: DK-1058

Country: DK

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

DKA Capital (formerly Dansk Kapitalanlæg) is a well-established Danish PE fund investing in and developing knowledge-intensive growth companies with a global potential with the aim of creating long term sustainable value. Since DKA Capital was founded in 1984, we have completed 180 investments and 175 exits of which 21 were in the form of IPO&s;s (Initial Public Offerings). This makes us one of the largest and most experienced investors in Denmark. The specialisation process in DKA Capital was initiated in 2006 and in 2011 the management of DKA Capital together Norwegian Argentum acquired 75% of the fund DKA II. DKA Capital has through DKA II 5 companies in its portfolio. DKA II is owned by the management of DKA Capital, Argentum, Nordea Liv &a; Pension and Danica Pension. We believe in direct and constructive communication leaving no doubt to what DKA Capital stands for or what we would like to achieve during our period of ownership. Together with the companies we execute professionally and create sense-of-urgency. DKA Capital&s;s aim is to be strategic and intelligent change of ownership. And we want to maintain our position as one of the most credible partners for knowledge-intensive growth companies. We invest in knowledge intensive companies with international growth opportunities. During the recent years we have marked ourselves as one of Denmark&s;s leading funds within this field.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
2/1997 Acadia Pharmaceuticals Inc. Series A 6M
5/2005 NsGene Venture Round 0
10/2010 Secunia Venture Round -
8/1997 Acadia Pharmaceuticals Inc. Series B 0
5/2000 HepaVec AG Series A 0
8/1998 Acadia Pharmaceuticals Inc. Series D 0
1/2021 CanopyLAB Debt Financing 0
4/2001 Develogen AG Series B 0
6/2000 Acadia Pharmaceuticals Inc. Debt Financing 0
1/2007 Hymite Series B 11.5M
7/2002 Direct Conversion Series B 21M
1/2021 CanopyLAB Debt Financing 0
10/2010 Secunia Venture Round -
1/2007 Hymite Series B 0
5/2005 NsGene Venture Round 0
7/2002 Direct Conversion Series B 0
4/2001 Develogen AG Series B 0
6/2000 Acadia Pharmaceuticals Inc. Debt Financing 0
5/2000 HepaVec AG Series A 0
8/1998 Acadia Pharmaceuticals Inc. Series D 0
8/1997 Acadia Pharmaceuticals Inc. Series B 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research